The present invention relates to Bcl-2 inhibitors and their use in the treatment of cell proliferative diseases such as cancer. The compounds of the invention may further act as HDAC inhibitors
-
Page/Page column 49
(2009/04/25)
More Articles about upstream products of 1012059-97-0